Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Endocrine drugs in development at Takeda

Sep. 27, 1996

U.S. clinical trials on nonsurgical alternative to hysterectomy ahead of schedule

Sep. 27, 1996

Aldose reductase inhibitors from Dainippon

Sep. 27, 1996

Antihyperglycemic agents from Wyeth-Ayerst

Sep. 27, 1996

Takeda's pipeline of metabolic drugs

Sep. 27, 1996

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

Tularik-Japan Tobacco leptin gene collaboration

Sep. 27, 1996

Lilly's antiobesity proteins

Sep. 27, 1996

Hypocholesterolemic and hypocholesterolemic/antioxidant compounds from Pierre Fabre

Sep. 27, 1996

Takeda reports new agent for improving lipid metabolism

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...